FDA and Regulation

NPA, cbdMD to outline CBD regulatory roadmap with virtual conference

The “Regulatory Roadmap for the CBD Industry” conference is slated for Oct. 21 at 10 a.m. Various moderators who will participate in a Q&A with NPA CEO Daniel Fabricant.

National Grocers Association backs CBD as a dietary supplement

The National Grocers Association (NGA) is supporting bipartisan legislation that would allow hemp-derived cannabidiol (CBD) to be regulated as dietary supplements, which the organization says would eliminate regulatory confusion and establish product manufacturing standards to support the

CHPA's virtual conference to include CBD regulation discussion

Many on-demand panels will feature discussions of such topics as CBD regulation and the quality and safety of supplement products.

Socati earns USDA Organic certification

The company has received official USDA Organic certification for its CBD ingredient lineup, which can be used in USDA Organic finished products.

FDA issues warnings to 2 companies marketing CBD as opioid alternatives

The Food and Drug Administration has sent warning letters to two companies it said were marketing products in a way that violates the Federal Food, Drug, and Cosmetic Act.

Charlotte’s Web gains hemp genetics patent

The latest patent marks the second one issued to Charlotte's Web for hemp genetics.

Summit Labs voluntarily recalls Kore Organic tincture lot, batch

Kore Organic is issuing a voluntary recall for one batch and lot of its Kore Organic Watermelon CBD Oil Tincture

Patriot Hemp cited by FDA, FTC over COVID-19 claims

The agencies cited AgroTerra, doing business as Patriot Hemp, for marketing its products with misleading claims that they are safe and effective in preventing COVID-19.